ICD-10-CM codes
The diagnosis classification on lab requisitions and clinical records. Every condition on this site is anchored to an ICD-10-CM code.
By chapter
22 chapters Certain infectious and parasitic diseases · A00–B99 1,307 Neoplasms · C00–D49 2,174 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism · D50–D89 398 Endocrine, nutritional and metabolic diseases · E00–E89 1,242 Mental, behavioral and neurodevelopmental disorders · F01–F99 1,112 Diseases of the nervous system · G00–G99 920 Diseases of the eye and adnexa · H00–H59 3,447 Diseases of the ear and mastoid process · H60–H95 871 Diseases of the circulatory system · I00–I99 1,793 Diseases of the respiratory system · J00–J99 471 Diseases of the digestive system · K00–K95 1,109 Diseases of the skin and subcutaneous tissue · L00–L99 1,072 Diseases of the musculoskeletal system and connective tissue · M00–M99 8,673 Diseases of the genitourinary system · N00–N99 1,037 Pregnancy, childbirth and the puerperium · O00–O9A 3,023 Certain conditions originating in the perinatal period · P00–P96 565 Congenital malformations, deformations and chromosomal abnormalities · Q00–Q99 1,055 Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified · R00–R99 938 Injury, poisoning and certain other consequences of external causes · S00–T88 53,983 Codes for special purposes · U00–U85 5 External causes of morbidity · V00–Y99 10,573 Factors influencing health status and contact with health services · Z00–Z99 1,816
All codes
97,584 codes · page 127 of 1,952
Progressive spinal muscle atrophy G12.25 Other motor neuron disease G12.29 Other spinal muscular atrophies and related syndromes G12.8 Spinal muscular atrophy, unspecified G12.9 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere G13 Paraneoplastic neuromyopathy and neuropathy G13.0 Other systemic atrophy primarily affecting central nervous system in neoplastic disease G13.1 Systemic atrophy primarily affecting the central nervous system in myxedema G13.2 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere G13.8 Postpolio syndrome G14 Parkinson's disease G20 Parkinson's disease without dyskinesia G20.A Parkinson's disease without dyskinesia, without mention of fluctuations G20.A1 Parkinson's disease without dyskinesia, with fluctuations G20.A2 Parkinson's disease with dyskinesia G20.B Parkinson's dis with dyskinesia, w/o mention of fluctuations Parkinson's disease with dyskinesia, without mention of fluctuations G20.B1 Parkinson's disease with dyskinesia, with fluctuations G20.B2 Parkinsonism, unspecified G20.C Secondary parkinsonism G21 Malignant neuroleptic syndrome G21.0 Other drug-induced secondary parkinsonism G21.1 Neuroleptic induced parkinsonism G21.11 Other drug induced secondary parkinsonism G21.19 Secondary parkinsonism due to other external agents G21.2 Postencephalitic parkinsonism G21.3 Vascular parkinsonism G21.4 Other secondary parkinsonism G21.8 Secondary parkinsonism, unspecified G21.9 Other degenerative diseases of basal ganglia G23 Hallervorden-Spatz disease G23.0 Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski] G23.1 Striatonigral degeneration G23.2 Hypomyelination with atrophy of basal ganglia and cerebellum Hypomyelination with atrophy of the basal ganglia and cerebellum G23.3 Other specified degenerative diseases of basal ganglia G23.8 Degenerative disease of basal ganglia, unspecified G23.9 Dystonia G24 Drug induced dystonia G24.0 Drug induced subacute dyskinesia G24.01 Drug induced acute dystonia G24.02 Other drug induced dystonia G24.09 Genetic torsion dystonia G24.1 Idiopathic nonfamilial dystonia G24.2 Spasmodic torticollis G24.3 Idiopathic orofacial dystonia G24.4 Blepharospasm G24.5 Other dystonia G24.8 Dystonia, unspecified G24.9 Other extrapyramidal and movement disorders G25 Essential tremor G25.0 Drug-induced tremor G25.1